Morgan Stanley has significantly raised its price target on Timken stock to $140 from $125 while maintaining an Overweight rating. The stock has surged 71% over the past year and currently trades at $117.20, with the new target implying approximately 25% upside potential. As reported by Investing.com, analyst Angel Castillo made this adjustment following the company's Investor Day presentation, viewing Timken's outlined path to organic sales growth and margin expansion as credible and conservative. The optimism is shared more broadly, with 6 analysts having revised their earnings upwards for the upcoming period.
Global brokerage houses Morgan Stanley and Goldman Sachs have retained bullish views on select Indian companies, maintaining optimistic outlooks despite near-term challenges. According to reports from The Economic Times, these brokerages continue to remain constructive on consumption, healthcare, and automobile stocks, driven by expectations of demand recovery, pricing power, and long-term growth visibility. The firms anticipate that companies will navigate margin pressures from rising commodity costs through strategic pricing adjustments and operational improvements.
The brokerages have highlighted LG Electronics India, Apollo Hospitals, and Maruti Suzuki India as key investment opportunities. As reported by The Economic Times, Morgan Stanley and Goldman Sachs cite strong revenue prospects, operational improvements, and strategic price adjustments as key factors supporting their bullish stance on these companies. The recommendations reflect confidence in these firms' ability to counter rising input costs while maintaining long-term growth trajectories. Morgan Stanley specifically maintains an overweight position on LG Electronics, while Goldman Sachs continues to maintain a buy rating on Apollo Hospitals.
The brokerage outlook comes amid expectations of demand recovery across key sectors. According to The Economic Times, the positive sentiment is driven by anticipation of improved market conditions and pricing power that companies are expected to leverage to offset commodity cost inflation. The recommendations suggest that despite near-term margin pressures from rising input costs, these companies are positioned to maintain growth momentum through strategic pricing and operational efficiency improvements.
Recent developments show Timken delivering exceptional results, with the company reporting strong first-quarter 2026 earnings that beat analyst expectations. The company achieved an adjusted earnings per share of $1.67, surpassing the forecasted $1.51, and reported revenue of $1.23 billion, exceeding the anticipated $1.17 billion. Additionally, Timken's total segment EBITDA reached $250 million, outperforming the Visible Alpha Consensus Data estimate of $234 million. The Industrial Motion segment's performance was notably strong, coming in 24% above consensus. Following these results, Goldman Sachs raised its price target for Timken to $117 from $105, maintaining a Neutral rating, while JPMorgan upgraded the stock rating to Neutral from Underweight, citing strong execution and performance exceeding near-term expectations.
